Navigation Links
HDSA Applauds Announcement of the First Therapy to be Approved for the Specific Treatment of a Symptom of Huntington's Disease
Date:8/15/2008

NEW YORK, Aug. 15 /PRNewswire/ -- The approval of Xenazine(R) (tetrabenazine), for the treatment of chorea associated with Huntington's Disease (HD), the first therapy to be approved specifically for the disease, is a significant milestone for all of our patients, families and caregivers in the HD community. Huntington's Disease Society of America (HDSA) is very pleased that we have the first treatment to alleviate one of the symptoms of this devastating disease.

"This is a great moment for our families, who have been waiting for answers to HD for a long time," said Barbara Boyle, National Executive Director/CEO of HDSA. "Our families should be proud that their advocacy efforts helped make a difference. We thank the developers of Xenazine for their work and perseverance, and look forward to more announcements of therapeutic approvals by the FDA in the near future. We will provide information on the future availability of Xenazine on our website (http://www.hdsa.org), and in our electronic and print publications as soon as details are provided to HDSA."

Huntington's Disease is a devastating, hereditary, degenerative brain disorder for which there is, at present, no effective treatment or cure. HD slowly diminishes the affected individual's ability to walk, think, talk and reason. Eventually, the person with HD becomes totally dependent upon others for his or her care. Huntington's Disease profoundly affects the lives of entire families -- emotionally, socially and economically. More than a quarter of a million Americans have HD or are "at risk" of inheriting the disease from an affected parent. HD affects as many people as Hemophilia, Cystic Fibrosis or ALS.

Early symptoms of Huntington's Disease may affect cognitive ability or mobility and include depression, mood swings, forgetfulness, clumsiness, involuntary twitching and lack of coordination. As the disease progresses, concentration and s
'/>"/>

SOURCE Huntington's Disease Society of America
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. AIDS Action Committee Applauds Legislature for Taking Action to Protect Patient Privacy Within New Electronic Medical Records System
2. AMA Applauds U.S. House for Acting to Protect Americans From the Dangers of Tobacco
3. CMMB Applauds America at Its Best as PEPFAR is Reauthorized by U.S. Government
4. AIDS Action Applauds Introduction of a New Bill Allowing Federal Funds to Support Syringe Exchange Programs
5. APHA Applauds Congressional Override of Medicare Veto
6. American Optometric Association Applauds Override of Medicare Cuts
7. ACP applauds Senate to vote to pass H.R. 6331 and avert physician payment cut
8. American Life League Applauds Congressional Action Against Planned Parenthood
9. NCOA Applauds Senate Passage of Medicare Bill
10. Kidney Community Applauds Senate for Passage of End Stage Renal Disease (ESRD) Improvements
11. Tubbs Jones Applauds Senate Passage of Medicare Improvements Bill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... The presence of chronic inflammation in benign ... prostate cancer, and this association was found even ... according to a study published in Cancer ... the American Association for Cancer Research. , An ... participants of the placebo arm of the Prostate ...
(Date:4/17/2014)... pain relief targets that could be used to ... King,s College London made the discovery when researching ... of the body. , Dr Marzia Malcangio said: ... pain generation and our findings could help chemotherapy ... One potential side effect of some chemotherapy drugs ...
(Date:4/17/2014)... April issue of Experimental Biology and Medicine ... Rex Gaskins and Paul Kenis in the Institute ... the University of Illinois Urbana-Champaign describe their recent ... underlie a variety of cell functions including energy ... crucial roles in regulating normal cellular behavior, redox ...
(Date:4/17/2014)... NY In a review published in the April ... president of The Feinstein Institute for Medical Research, says ... medical community,s approach to treating sepsis, which ... Americans. , Sepsis occurs when molecules released into the ... throughout the body. Inflammation is necessary for maintaining good ...
(Date:4/17/2014)... NY, April 17, 2014U.S. military personnel who served ... impact" concussive traumatic brain injury (TBI) were compared ... for other medical reasons. Differences in measures of ... 6-12 months after injury are reported in an ... peer-reviewed journal from Mary Ann Liebert, Inc., publishers. ...
Breaking Medicine News(10 mins):Health News:Chronic inflammation may be linked to aggressive prostate cancer 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 3Health News:New pain relief targets discovered 2Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2
... 7 (HealthDay News) -- The first study to focus solely ... survived the Sept. 11, 2001 attacks on the World Trade ... In fact, of the 3,271 evacuees of the Twin Towers ... suffered from at least one current post-traumatic stress symptom, while ...
... of the symptoms of Fragile X, the most common cause ... new study published in the January 5 issue of ... helped design the study and are now participating in the ... trial of 30 Fragile X patients, found the drug, called ...
... 7 (HealthDay News) -- Making decisions about breast cancer ... level and ability to enjoy normal life activities is most ... the primary outcome, a new Canadian study shows. Researchers ... of breast cancer treatments and found that quality of life ...
... ANTONIO (Jan. 7, 2011) Just 5 percent of Parkinson,s ... rest have no known cause. But a new discovery by ... Antonio may begin to explain why the vast majority of ... in the Journal of Neuroscience , the researchers demystified ...
... greatest human-made disaster in U.S. history-- the destruction of the ... research documenting the attacks, consequences among those most directly affected ... In a study just released by Columbia University,s Mailman ... City Department of Health and Mental Hygiene and the federal ...
... A new study finds that people with high levels of ... likely to have other areas of the body colonized by ... Rhode Island Hospital wanted to assess the quantity of MRSA ... the quantities of MRSA at different locations. The investigators ...
Cached Medicine News:Health News:Many Survivors of World Trade Center Attacks Suffered PTSD: Study 2Health News:Study shows promise for new drug to treat Fragile X 2Health News:Quality of Life Key Measure in Breast Cancer Clinical Trials 2Health News:Scientists shed light on what causes brain cell death in Parkinson's patients 2Health News:More than 3,000 survivors of the WTC attacks experience long-term post-traumatic stress disorder 2Health News:More than 3,000 survivors of the WTC attacks experience long-term post-traumatic stress disorder 3
(Date:1/15/2014)... , Jan. 15, 2014  A novel wearable injector slightly larger ... painless for patients to self-inject prescription drugs in the large ... cancer, blood diseases, autoimmune deficiencies, and genetic disorders.  ... to $220B by 2018, according to analysts.   Many of these ...
(Date:1/14/2014)... N.J. , Jan. 14, 2014 InformEx, ... and sellers of high-value chemistry, will hold the 30 th ... Miami Beach Convention Center from January 21-24. ... 3,500 attendees from top pharmaceutical, fine chemical and specialty chemical ...
(Date:1/14/2014)... Jan. 14, 2014 /PRNewswire-iReach/ -- Acumed,s new SLIC Screw ... with accompanying instrumentation to place and insert the screw ... soft tissue (e.g. ligament) repair or reconstruction as it ... (Photo: http://photos.prnewswire.com/prnh/20140114/MN45636 ) ...
Breaking Medicine Technology:Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 2Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 3
... DETROIT, Nov. 6 Caraco Pharmaceutical Laboratories, Ltd. ... tromethamine ophthalmic solution, 0.5% following a final approval ... for Sun Pharma,s Abbreviated New Drug Application (ANDA) ... day following patent expiration. This strength of ketorolac ...
... SAN DIEGO, Nov. 6 NuVasive, Inc. (Nasdaq: ... products for minimally disruptive surgical treatments for the spine, ... Executive Vice President and Chief Financial Officer, effective November ... Executive Management Team updates. , "Michael will be an ...
Cached Medicine Technology:Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Ophthalmic Solution 2NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 2NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 3NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 4NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 5
KIMBERLY-CLARK BALLARD Neonatal and Pediatric TRACH CARE Y features lavage/irrigation port and locking thumb port. Multiple French sizes and packaging configurations. Gamma sterilized....
... Ruschelit® PVC siliconized. Stainless steel spiral reinforced. ... band. Single use. Adjustable Flange: The flange can ... the thickness of the cervical soft tissue. The ... is tightly connected to the shaft. Maximum Patient ...
... Cuffed tubes include ... tube holder, disconnect wedge, ... and two inner cannulae., ... an obturator, Velcro® trach ...
... are a dual cannula system ... disposable inner cannula recommended. One ... the procedural tray. Additional inner ... available separately. Per-fit™ kits are ...
Medicine Products: